Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) this morning announced that it has identified improved performance features of a new version of the DehydraTECH(TM) delivery platform primarily suitable for…
Global technology and value-added solutions group Net Element (NASDAQ: NETE) today announced that it has launched Blade, its proprietary, fully-automated underwriting solution with predictive scoring powered by artificial intelligence (“AI”). Per the update, Blade is…
A presentation by INMB co-founder and CFO David Moss is slated for June 5 at 10:20 a.m., with one-on-one meetings also available The company’s active drug candidates are INKmune and INB03, which may be used…
TransCanna Holdings (CSE: TCAN) (FSE: TH8) today announced that its wholly owned subsidiary, TCM Distribution, Inc., has received an adult use cannabis manufacturing permit and an adult use cannabis distribution permit from the City of…
The global precision medicine market is expected to reach revenues of over $216.75 billion by 2028, propelled by a growing interest in personalized approaches to disease treatments and the application of new technologies Precision Therapeutics…